2022
DOI: 10.3390/vaccines10040581
|View full text |Cite
|
Sign up to set email alerts
|

Detection of Anti-SARS-CoV-2-S1 RBD-Specific Antibodies Prior to and during the Pandemic in 2011–2021 and COVID-19 Observational Study in 2019–2021

Abstract: Background: Longitudinal surveys to monitor the seroprevalence are required to support efforts for assessment of the levels of endemic stability in certain countries. We investigated seroprevalence of anti-SARS-CoV-2-S1 receptor-binding domain (RBD)-specific antibodies in the serum samples in 2011–2021, including a cohort study of 2019–2021, to evaluate the vaccination and anti-IgG-SARS-CoV-2–S1 RBD-positive statuses to assess the resistance and severity of COVID-19. Materials and Methods: Anti-SARS-CoV-2-S1 R… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(10 citation statements)
references
References 17 publications
0
9
0
Order By: Relevance
“…Difficulties in comparing serological data obtained using various commercial test systems are caused by several reasons because of not only clinical but also genetic, immunological, environmental and stochastic factors affect the assessment of the humoral response to pathogens magnitude [12] , [13] , [14] , [15] , [16] . The few literature data on this subject are contradictory.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Difficulties in comparing serological data obtained using various commercial test systems are caused by several reasons because of not only clinical but also genetic, immunological, environmental and stochastic factors affect the assessment of the humoral response to pathogens magnitude [12] , [13] , [14] , [15] , [16] . The few literature data on this subject are contradictory.…”
Section: Discussionmentioning
confidence: 99%
“…Seroconversion almost always occurs after confirmed COVID-19 even if the disease is mild [9] , [10] , [11] . The rate of formation and persistence of antibodies against SARS-CoV-2 depends on many factors: the severity of the disease and the time of blood sampling after the onset of COVID-19 symptoms [ 12 , 13 ], age [14] , cross-reactions due to previous diseases with coronaviruses of previous generations and vaccination with non-specific vaccines [15] and genetics component [ 16 , 17 ]. The antibodies blood level is affected by the functional of innant immunity as well as the balance between the links of adaptive immunity - cellular and humoral.…”
Section: Introductionmentioning
confidence: 99%
“…Several hypotheses were proposed to explain this lesser disease burden, including a younger demographic structure in SSA ( 2 ), less testing, undercounting of deaths, genetic predispositions, and cross-reactive immunity against previous coronaviruses. Pre-existing cross-reactive immune responses have been reported in many geographical locations ( 3 6 ) and in some cases were significantly higher in SSA than in other continents ( 4 ), probably due to the high sequence homology between SARS-CoV-2 and the common coronaviruses in SSA. Such cross-reactive immune responses to other coronaviruses were linked to a decreased likelihood of COVID-19 disease severity in the United States ( 7 ), but not in other regions, such as SSA ( 8 10 ).…”
Section: Introductionmentioning
confidence: 99%
“…Inclusion criteria were subjects over 18 years of age who volunteered to participate in the microcirculation study. The participants were recruited in 2019 (N = 80), 2020 (N = 129), and 2021 (N = 98) in National Research Center for Preventive Medicine (NRCPM), Moscow, Russia [ 7 ]. Evaluation of the participants included assessment of baseline cardiovascular characteristics by echocardiography, SCORE index calculation and biochemical parameters in the blood at the time of the recruitment visit.…”
Section: Methodsmentioning
confidence: 99%
“…Echocardiography is a widely available method of assessment of the structural and functional characteristics of the heart. We aimed to compare the echocardiographic characteristics and the levels of routine blood markers in healthy participants recruited in a 2019–2021 study originally unrelated to COVID-19 [ 7 ]. The recruitment of this cohort was initiated before the pandemic and continued during the pandemic, and the data were used for comparative analysis of the groups of immunoglobulin G antibodies against severe acute respiratory syndrome-linked coronavirus (IgG-SARS)-positive and IgG-SARS-negative participants in the present study.…”
Section: Introductionmentioning
confidence: 99%